Press releases

February 1, 2026

Lympha Bio Awarded $50,000 VIPC Launch Grant to Advance Human Immune-Modeling Platform
November 1, 2025

Lympha Bio Launches to Bring Human-Relevant Immune Modeling to Drug Development

Follow Lympha Bio On LinkedIn

In the news

Virginia Tech News, 06/2025

Lymph node on a chip: New immune system model developed to enhance precision medicine research

The Roanoke Star, 06/2025

Lymph Node-on-a-Chip Model Advances Immune Research at VA Tech

Forward Pathway, 06/2025

Revolutionizing Drug Development and Precision Medicine

UVA Today, 10/2019

UVA Team Wins $2.4 Million NIH Grant to Develop Mini-Lymph Node Model

Lab on a Chip, 06/2018

Emerging Investigator Series – Rebecca Pompano

MILESTONES

Federally and institutionally backed

$3.5M NIH NCATS U01

Tissue Chip Consortium funding for enabling technology, 2019–2026

HeroX Complement-ARIE Challenge Prize

Awarded 2024 for innovation in human-relevant biomedical research tools

$50K VIPC Launch Grant

Virginia Innovation Partnership Corporation, awarded December 2025

2018

• First US Patent Application filed for enabling lymhoid-patterned in vitro test system (App. 17/045,459).

2019-2024

• $3.5M NIH NCATS U01 grant (EB029127) funds the Tissue Chip Consortium enabling technology at UVA and Virginia Tech.
• Ozulumba et al. published in Frontiers in Immunology.
• HeroX Complement-ARIE Challenge Prize awarded to the leadership team.

2025 - Company Formation

• Lympha Bio incorporated to translate this technology.
• $50,000 Launch Grant awarded by Virginia Innovation Partnership Corporation (VIPC) to Lympha Bio.

2026

• Steps towards MVP validation of LymphaTox I.
• Lympha Bio joins Charlottesville BioHub C-Suite Program
• New IP filed on the latest technology.

News & Milestones